Sign in
SCHEDULE 13G

Statement of Beneficial Ownership

Perspective Therapeutics, Inc. Filed Acc 0002012383-26-002804

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-12 SCHEDULE 13D/A · Lantheus Holdings, Inc. 3.9%
  2. 2026-09-23 SCHEDULE 13D/A · Lantheus Holdings, Inc. 7.7%
  3. 2026-09-04 SCHEDULE 13D/A · Lantheus Holdings, Inc. 10.0%
Loading xslSCHEDULE_13G_X02/primary_doc.xml…